FDA Approved

semaglutide

OzempicWegovy

Manufactured by Novo Nordisk

Available Brands

Ozempic

FDA-approved for type 2 diabetes, CV risk reduction, and kidney disease. Weekly injection.

See Ozempic savings and coverage →

Wegovy

FDA-approved for chronic weight management. Available as weekly injection or daily pill.

See Wegovy savings and coverage →

Overview

FDA Status

FDA Approved

Route

injection

Approved Indications

Weight ManagementType2 Diabetes

Dosing

Typical Dose Range

0.25mg - 2.4mg weekly

Dosing is determined by your prescribing provider based on your individual needs. Most GLP-1 medications follow a gradual titration schedule, starting at a low dose and increasing over several weeks to reduce side effects.

Cost Breakdown

Branded (Retail)

$1,300/mo

Savings Program

$499/mo

Prices are estimates and may vary by pharmacy, location, and insurance coverage. Contact your provider for accurate pricing.

Common Side Effects

  • nausea
  • vomiting
  • diarrhea
  • constipation
  • abdominal pain

This is not a complete list of side effects. Talk to your healthcare provider about what to expect and when to seek medical attention.

This site is for educational purposes only and is not medical advice. Always consult a healthcare provider before starting any medication. Full disclaimer

Deeper dive

Complete Wegovy guide for 2026

Wegovy is the FDA-approved semaglutide brand for weight loss, available as both a weekly pen and a once-daily pill. See our full pillar covering every coupon, cost breakdown, and access path.

Related Articles